2024-514725-38-00招募中4 期
A randomized, single dose, cross-over, replicated, open-label bioequivalence study comparing indacaterol/glycopyrronium (85/43mcg inhalation powder hard capsules) (PG341 [Celon Pharma] vs Ultibro Breezhaler [Novartis])
Celon Pharma S.A.1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年11月18日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical trial information point
Scientific
Celon Pharma S.A.
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A single dose, open-label, randomised, cross-over bioequivalence study in healthy young men comparing two formulations of escitalopram: the conventional immediate release tablet and the to be marketed orally dispersible tabletdepressive disorder10027946depressionNL-OMON32586undbeck30
已完成
不适用
A single dose, open-label, randomised, cross-over bioequivalence study in healthy young men comparing two formulations of escitalopram orally dispersible tabletsdepressionNL-OMON32494undbeck18
已完成
3 期
A randomised, single dose, crossover, open label, placebo controlled confirmatory study in healthy volunteers to characterise the acid neutralisation activity of Gaviscon Double Action Liquid in the fasted state, using an intragastric and oesophageal pH catheter.GORDgastric acid refluxHealthy volunteersheartburn10017947NL-OMON44533Reckitt Benckiser Healthcare (UK) Ltd12
进行中（未招募）
1 期
Gaviscon Double Action Liquid pH Monitoring StudyTo investigate the pH of the acid in the stomach of healthy volunteers after the intakeof Gaviscon Double Action liquid.EUCTR2016-000539-42-NLReckitt Benckiser Healthcare (UK) Limited20
撤回
3 期
A randomised, single dose, crossover, open label, placebo controlled confirmatory study with interim analysis in healthy volunteers to characterise the acid neutralisation activity of Gaviscon Double Action Tablets in the fasted state, using an intragastric and oesophageal pH catheterGORDgastric acid refluxHealthy volunteersheartburn10017947NL-OMON42922Reckitt Benckiser Healthcare (Ltd) UK12